HEADER HYDROLASE 01-MAY-17 5VNP TITLE X-RAY CRYSTAL STRUCTURE OF HALOTAG BOUND TO THE P1 BENZOXADIAZOLE TITLE 2 FLUOROGENIC LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: HALOALKANE DEHALOGENASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.8.1.5; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RHODOCOCCUS RHODOCHROUS; SOURCE 3 ORGANISM_TAXID: 1829; SOURCE 4 GENE: DHAA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS BIOSENSOR, CYTOTOXICITY, FLUORESCENT PROBE, PROTEIN AGGREGATION, KEYWDS 2 PROTEOME STRESS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR N.P.DUNHAM,A.K.BOAL REVDAT 3 22-NOV-17 5VNP 1 REMARK REVDAT 2 26-JUL-17 5VNP 1 JRNL REVDAT 1 14-JUN-17 5VNP 0 JRNL AUTH Y.LIU,M.FARES,N.P.DUNHAM,Z.GAO,K.MIAO,X.JIANG,S.S.BOLLINGER, JRNL AUTH 2 A.K.BOAL,X.ZHANG JRNL TITL AGHALO: A FACILE FLUOROGENIC SENSOR TO DETECT DRUG-INDUCED JRNL TITL 2 PROTEOME STRESS. JRNL REF ANGEW. CHEM. INT. ED. ENGL. V. 56 8672 2017 JRNL REFN ESSN 1521-3773 JRNL PMID 28557281 JRNL DOI 10.1002/ANIE.201702417 REMARK 2 REMARK 2 RESOLUTION. 2.23 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.23 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 24385 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1299 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.23 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1349 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 74.42 REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4656 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.51000 REMARK 3 B22 (A**2) : -0.46000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.36000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.435 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.232 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.183 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.497 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4884 ; 0.005 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4578 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6676 ; 0.974 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10556 ; 0.730 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 578 ; 4.477 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 228 ;28.856 ;23.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 734 ;12.099 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;13.164 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 704 ; 0.055 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5438 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1126 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5VNP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1000227736. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26164 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.230 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.14100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.23 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.61600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5UY1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, SODIUM ACETATE, SODIUM REMARK 280 CACODYLATE, PH 6.5, EVAPORATION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.74050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 105 CG ASP A 105 OD2 0.187 REMARK 500 ASP B 105 CG ASP B 105 OD2 0.191 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 30 35.11 -98.00 REMARK 500 PRO A 41 50.50 -107.22 REMARK 500 THR A 42 -169.25 -102.70 REMARK 500 GLU A 97 -84.47 -91.36 REMARK 500 ASP A 105 -126.88 57.96 REMARK 500 ASP A 155 -69.06 -98.23 REMARK 500 VAL A 244 -66.27 -136.47 REMARK 500 LEU A 270 -96.09 -121.96 REMARK 500 PRO B 41 46.51 -105.40 REMARK 500 THR B 42 -169.84 -100.68 REMARK 500 GLU B 97 -77.87 -105.66 REMARK 500 ASP B 105 -131.27 59.74 REMARK 500 GLU B 129 62.58 39.16 REMARK 500 ARG B 152 48.04 -86.89 REMARK 500 VAL B 244 -67.74 -133.80 REMARK 500 LEU B 270 -92.43 -120.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9FM A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide 9FM B 301 and ASP B REMARK 800 105 DBREF 5VNP A 3 292 UNP P0A3G2 DHAA_RHORH 4 293 DBREF 5VNP B 3 292 UNP P0A3G2 DHAA_RHORH 4 293 SEQADV 5VNP VAL A 46 UNP P0A3G2 LEU 47 CONFLICT SEQADV 5VNP THR A 57 UNP P0A3G2 SER 58 CONFLICT SEQADV 5VNP GLY A 77 UNP P0A3G2 ASP 78 CONFLICT SEQADV 5VNP PHE A 86 UNP P0A3G2 TYR 87 CONFLICT SEQADV 5VNP MET A 87 UNP P0A3G2 LEU 88 CONFLICT SEQADV 5VNP PHE A 127 UNP P0A3G2 CYS 128 CONFLICT SEQADV 5VNP THR A 154 UNP P0A3G2 ALA 155 CONFLICT SEQADV 5VNP LYS A 159 UNP P0A3G2 GLU 160 CONFLICT SEQADV 5VNP VAL A 166 UNP P0A3G2 ALA 167 CONFLICT SEQADV 5VNP THR A 171 UNP P0A3G2 ALA 172 CONFLICT SEQADV 5VNP MET A 174 UNP P0A3G2 LYS 175 CONFLICT SEQADV 5VNP GLY A 175 UNP P0A3G2 CYS 176 CONFLICT SEQADV 5VNP ASN A 194 UNP P0A3G2 LYS 195 CONFLICT SEQADV 5VNP GLU A 223 UNP P0A3G2 ALA 224 CONFLICT SEQADV 5VNP ASP A 226 UNP P0A3G2 ASN 227 CONFLICT SEQADV 5VNP LYS A 256 UNP P0A3G2 GLU 257 CONFLICT SEQADV 5VNP ALA A 263 UNP P0A3G2 THR 264 CONFLICT SEQADV 5VNP ASN A 271 UNP P0A3G2 HIS 272 CONFLICT SEQADV 5VNP LEU A 272 UNP P0A3G2 TYR 273 CONFLICT SEQADV 5VNP SER A 290 UNP P0A3G2 PRO 291 CONFLICT SEQADV 5VNP THR A 291 UNP P0A3G2 ALA 292 CONFLICT SEQADV 5VNP VAL B 46 UNP P0A3G2 LEU 47 CONFLICT SEQADV 5VNP THR B 57 UNP P0A3G2 SER 58 CONFLICT SEQADV 5VNP GLY B 77 UNP P0A3G2 ASP 78 CONFLICT SEQADV 5VNP PHE B 86 UNP P0A3G2 TYR 87 CONFLICT SEQADV 5VNP MET B 87 UNP P0A3G2 LEU 88 CONFLICT SEQADV 5VNP PHE B 127 UNP P0A3G2 CYS 128 CONFLICT SEQADV 5VNP THR B 154 UNP P0A3G2 ALA 155 CONFLICT SEQADV 5VNP LYS B 159 UNP P0A3G2 GLU 160 CONFLICT SEQADV 5VNP VAL B 166 UNP P0A3G2 ALA 167 CONFLICT SEQADV 5VNP THR B 171 UNP P0A3G2 ALA 172 CONFLICT SEQADV 5VNP MET B 174 UNP P0A3G2 LYS 175 CONFLICT SEQADV 5VNP GLY B 175 UNP P0A3G2 CYS 176 CONFLICT SEQADV 5VNP ASN B 194 UNP P0A3G2 LYS 195 CONFLICT SEQADV 5VNP GLU B 223 UNP P0A3G2 ALA 224 CONFLICT SEQADV 5VNP ASP B 226 UNP P0A3G2 ASN 227 CONFLICT SEQADV 5VNP LYS B 256 UNP P0A3G2 GLU 257 CONFLICT SEQADV 5VNP ALA B 263 UNP P0A3G2 THR 264 CONFLICT SEQADV 5VNP ASN B 271 UNP P0A3G2 HIS 272 CONFLICT SEQADV 5VNP LEU B 272 UNP P0A3G2 TYR 273 CONFLICT SEQADV 5VNP SER B 290 UNP P0A3G2 PRO 291 CONFLICT SEQADV 5VNP THR B 291 UNP P0A3G2 ALA 292 CONFLICT SEQRES 1 A 290 ILE GLY THR GLY PHE PRO PHE ASP PRO HIS TYR VAL GLU SEQRES 2 A 290 VAL LEU GLY GLU ARG MET HIS TYR VAL ASP VAL GLY PRO SEQRES 3 A 290 ARG ASP GLY THR PRO VAL LEU PHE LEU HIS GLY ASN PRO SEQRES 4 A 290 THR SER SER TYR VAL TRP ARG ASN ILE ILE PRO HIS VAL SEQRES 5 A 290 ALA PRO THR HIS ARG CYS ILE ALA PRO ASP LEU ILE GLY SEQRES 6 A 290 MET GLY LYS SER ASP LYS PRO ASP LEU GLY TYR PHE PHE SEQRES 7 A 290 ASP ASP HIS VAL ARG PHE MET ASP ALA PHE ILE GLU ALA SEQRES 8 A 290 LEU GLY LEU GLU GLU VAL VAL LEU VAL ILE HIS ASP TRP SEQRES 9 A 290 GLY SER ALA LEU GLY PHE HIS TRP ALA LYS ARG ASN PRO SEQRES 10 A 290 GLU ARG VAL LYS GLY ILE ALA PHE MET GLU PHE ILE ARG SEQRES 11 A 290 PRO ILE PRO THR TRP ASP GLU TRP PRO GLU PHE ALA ARG SEQRES 12 A 290 GLU THR PHE GLN ALA PHE ARG THR THR ASP VAL GLY ARG SEQRES 13 A 290 LYS LEU ILE ILE ASP GLN ASN VAL PHE ILE GLU GLY THR SEQRES 14 A 290 LEU PRO MET GLY VAL VAL ARG PRO LEU THR GLU VAL GLU SEQRES 15 A 290 MET ASP HIS TYR ARG GLU PRO PHE LEU ASN PRO VAL ASP SEQRES 16 A 290 ARG GLU PRO LEU TRP ARG PHE PRO ASN GLU LEU PRO ILE SEQRES 17 A 290 ALA GLY GLU PRO ALA ASN ILE VAL ALA LEU VAL GLU GLU SEQRES 18 A 290 TYR MET ASP TRP LEU HIS GLN SER PRO VAL PRO LYS LEU SEQRES 19 A 290 LEU PHE TRP GLY THR PRO GLY VAL LEU ILE PRO PRO ALA SEQRES 20 A 290 GLU ALA ALA ARG LEU ALA LYS SER LEU PRO ASN CYS LYS SEQRES 21 A 290 ALA VAL ASP ILE GLY PRO GLY LEU ASN LEU LEU GLN GLU SEQRES 22 A 290 ASP ASN PRO ASP LEU ILE GLY SER GLU ILE ALA ARG TRP SEQRES 23 A 290 LEU SER THR LEU SEQRES 1 B 290 ILE GLY THR GLY PHE PRO PHE ASP PRO HIS TYR VAL GLU SEQRES 2 B 290 VAL LEU GLY GLU ARG MET HIS TYR VAL ASP VAL GLY PRO SEQRES 3 B 290 ARG ASP GLY THR PRO VAL LEU PHE LEU HIS GLY ASN PRO SEQRES 4 B 290 THR SER SER TYR VAL TRP ARG ASN ILE ILE PRO HIS VAL SEQRES 5 B 290 ALA PRO THR HIS ARG CYS ILE ALA PRO ASP LEU ILE GLY SEQRES 6 B 290 MET GLY LYS SER ASP LYS PRO ASP LEU GLY TYR PHE PHE SEQRES 7 B 290 ASP ASP HIS VAL ARG PHE MET ASP ALA PHE ILE GLU ALA SEQRES 8 B 290 LEU GLY LEU GLU GLU VAL VAL LEU VAL ILE HIS ASP TRP SEQRES 9 B 290 GLY SER ALA LEU GLY PHE HIS TRP ALA LYS ARG ASN PRO SEQRES 10 B 290 GLU ARG VAL LYS GLY ILE ALA PHE MET GLU PHE ILE ARG SEQRES 11 B 290 PRO ILE PRO THR TRP ASP GLU TRP PRO GLU PHE ALA ARG SEQRES 12 B 290 GLU THR PHE GLN ALA PHE ARG THR THR ASP VAL GLY ARG SEQRES 13 B 290 LYS LEU ILE ILE ASP GLN ASN VAL PHE ILE GLU GLY THR SEQRES 14 B 290 LEU PRO MET GLY VAL VAL ARG PRO LEU THR GLU VAL GLU SEQRES 15 B 290 MET ASP HIS TYR ARG GLU PRO PHE LEU ASN PRO VAL ASP SEQRES 16 B 290 ARG GLU PRO LEU TRP ARG PHE PRO ASN GLU LEU PRO ILE SEQRES 17 B 290 ALA GLY GLU PRO ALA ASN ILE VAL ALA LEU VAL GLU GLU SEQRES 18 B 290 TYR MET ASP TRP LEU HIS GLN SER PRO VAL PRO LYS LEU SEQRES 19 B 290 LEU PHE TRP GLY THR PRO GLY VAL LEU ILE PRO PRO ALA SEQRES 20 B 290 GLU ALA ALA ARG LEU ALA LYS SER LEU PRO ASN CYS LYS SEQRES 21 B 290 ALA VAL ASP ILE GLY PRO GLY LEU ASN LEU LEU GLN GLU SEQRES 22 B 290 ASP ASN PRO ASP LEU ILE GLY SER GLU ILE ALA ARG TRP SEQRES 23 B 290 LEU SER THR LEU HET 9FM A 301 32 HET CL A 302 1 HET 9FM B 301 32 HET CL B 302 1 HETNAM 9FM N-{2-[2-(HEXYLOXY)ETHOXY]ETHYL}-N~2~-METHYL-N~2~-{[7- HETNAM 2 9FM (METHYLAMINO)-2,1,3-BENZOXADIAZOL-4- HETNAM 3 9FM YL]SULFONYL}GLYCINAMIDE HETNAM CL CHLORIDE ION FORMUL 3 9FM 2(C20 H33 N5 O6 S) FORMUL 4 CL 2(CL 1-) FORMUL 7 HOH *81(H2 O) HELIX 1 AA1 SER A 43 ARG A 48 5 6 HELIX 2 AA2 ILE A 50 ALA A 55 1 6 HELIX 3 AA3 PHE A 79 LEU A 94 1 16 HELIX 4 AA4 ASP A 105 ASN A 118 1 14 HELIX 5 AA5 THR A 136 TRP A 140 5 5 HELIX 6 AA6 PRO A 141 PHE A 143 5 3 HELIX 7 AA7 ALA A 144 ARG A 152 1 9 HELIX 8 AA8 ASP A 155 ILE A 162 1 8 HELIX 9 AA9 ASN A 165 GLY A 170 1 6 HELIX 10 AB1 GLY A 170 GLY A 175 1 6 HELIX 11 AB2 THR A 181 GLU A 190 1 10 HELIX 12 AB3 PRO A 191 LEU A 193 5 3 HELIX 13 AB4 ASN A 194 ASP A 197 5 4 HELIX 14 AB5 ARG A 198 LEU A 208 1 11 HELIX 15 AB6 PRO A 214 SER A 231 1 18 HELIX 16 AB7 PRO A 247 LEU A 258 1 12 HELIX 17 AB8 LEU A 272 ASN A 277 1 6 HELIX 18 AB9 ASN A 277 LEU A 292 1 16 HELIX 19 AC1 SER B 43 ARG B 48 5 6 HELIX 20 AC2 ILE B 50 ALA B 55 1 6 HELIX 21 AC3 PHE B 79 LEU B 94 1 16 HELIX 22 AC4 ASP B 105 ASN B 118 1 14 HELIX 23 AC5 THR B 136 TRP B 140 5 5 HELIX 24 AC6 PRO B 141 PHE B 143 5 3 HELIX 25 AC7 ALA B 144 ARG B 152 1 9 HELIX 26 AC8 ASP B 155 ILE B 162 1 8 HELIX 27 AC9 ASN B 165 GLY B 170 1 6 HELIX 28 AD1 LEU B 172 VAL B 176 5 5 HELIX 29 AD2 THR B 181 GLU B 190 1 10 HELIX 30 AD3 PRO B 191 LEU B 193 5 3 HELIX 31 AD4 ASN B 194 ASP B 197 5 4 HELIX 32 AD5 ARG B 198 LEU B 208 1 11 HELIX 33 AD6 PRO B 214 SER B 231 1 18 HELIX 34 AD7 PRO B 247 LEU B 258 1 12 HELIX 35 AD8 LEU B 272 ASN B 277 1 6 HELIX 36 AD9 ASN B 277 LEU B 292 1 16 SHEET 1 AA1 8 HIS A 12 VAL A 16 0 SHEET 2 AA1 8 GLU A 19 VAL A 26 -1 O GLU A 19 N VAL A 16 SHEET 3 AA1 8 CYS A 60 PRO A 63 -1 O CYS A 60 N VAL A 26 SHEET 4 AA1 8 VAL A 34 LEU A 37 1 N PHE A 36 O ILE A 61 SHEET 5 AA1 8 VAL A 99 HIS A 104 1 O VAL A 100 N LEU A 35 SHEET 6 AA1 8 VAL A 122 MET A 128 1 O ALA A 126 N LEU A 101 SHEET 7 AA1 8 LYS A 235 PRO A 242 1 O LEU A 236 N PHE A 127 SHEET 8 AA1 8 CYS A 261 GLY A 269 1 O ILE A 266 N TRP A 239 SHEET 1 AA2 8 HIS B 12 VAL B 16 0 SHEET 2 AA2 8 GLU B 19 VAL B 26 -1 O GLU B 19 N VAL B 16 SHEET 3 AA2 8 CYS B 60 PRO B 63 -1 O CYS B 60 N VAL B 26 SHEET 4 AA2 8 VAL B 34 LEU B 37 1 N PHE B 36 O ILE B 61 SHEET 5 AA2 8 VAL B 99 HIS B 104 1 O VAL B 100 N LEU B 35 SHEET 6 AA2 8 VAL B 122 MET B 128 1 O ALA B 126 N LEU B 101 SHEET 7 AA2 8 LYS B 235 PRO B 242 1 O LEU B 236 N PHE B 127 SHEET 8 AA2 8 CYS B 261 GLY B 269 1 O VAL B 264 N LEU B 237 LINK OD2 ASP A 105 C32 9FM A 301 1555 1555 1.41 LINK OD2 ASP B 105 C32 9FM B 301 1555 1555 1.42 CISPEP 1 ASN A 40 PRO A 41 0 -1.60 CISPEP 2 GLU A 213 PRO A 214 0 -5.04 CISPEP 3 THR A 241 PRO A 242 0 2.62 CISPEP 4 ASN B 40 PRO B 41 0 -0.08 CISPEP 5 GLU B 213 PRO B 214 0 -5.01 CISPEP 6 THR B 241 PRO B 242 0 0.87 SITE 1 AC1 9 ASP A 105 THR A 147 PHE A 148 GLN A 164 SITE 2 AC1 9 VAL A 166 THR A 171 MET A 174 ASN A 271 SITE 3 AC1 9 CL A 302 SITE 1 AC2 4 ASN A 40 TRP A 106 PRO A 205 9FM A 301 SITE 1 AC3 4 ASN B 40 TRP B 106 PRO B 205 9FM B 301 SITE 1 AC4 18 GLY B 39 ASN B 40 HIS B 104 TRP B 106 SITE 2 AC4 18 GLY B 107 SER B 108 ALA B 109 GLU B 129 SITE 3 AC4 18 ILE B 131 ALA B 144 THR B 147 GLY B 170 SITE 4 AC4 18 THR B 171 MET B 174 GLY B 175 LEU B 245 SITE 5 AC4 18 ASN B 271 CL B 302 CRYST1 44.272 69.481 88.950 90.00 95.82 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022588 0.000000 0.002302 0.00000 SCALE2 0.000000 0.014392 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011301 0.00000 MASTER 307 0 4 36 16 0 10 6 0 0 0 46 END